Glucose tracker could catch transplant trouble early
NCT ID NCT07470593
First seen Mar 24, 2026 · Last updated Jun 12, 2026 · Updated 9 times
Summary
This study looks at whether a continuous glucose monitor (CGM) can help detect early loss of function in transplanted pancreatic islet cells. Researchers will track 36 adults with type 1 diabetes who have already received an islet transplant. The goal is to see if a drop in "time in tight range" (blood sugar between 70-140 mg/dL) signals that the transplant is starting to fail.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopitaux Universitaires de Strasbourg
RECRUITINGStrasbourg, 67200, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.